Sunesis Pharmaceuticals' IPO

Sunesis Pharmaceuticals raised a round of funding on September 15, 2005. Investors include Public.

Sunesis is an oncology company developing cell-cycle inhibitors with a method of discovering drugs in pieces, or fragments. This Tethering is a process whereby the fragment is built out using the targ…

Articles about Sunesis Pharmaceuticals' IPO: